Fainstein V - Search Results

1

Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients.

Fainstein V, Bodey GP, Elting L, Maksymiuk A, Keating M, McCredie KB. Fainstein V, et al. Antimicrob Agents Chemother. 1987 Jan;31(1):11-5. doi: 10.1128/AAC.31.1.11. Antimicrob Agents Chemother. 1987. PMID: 3566234 Free PMC article. Clinical Trial.

2

Ceftizoxime plus ticarcillin: double beta-lactam therapy for infections in cancer patients.

Rolston KV, Jones PG, Fainstein V, Elting L, Bodey GP. Rolston KV, et al. Among authors: fainstein v. J Antimicrob Chemother. 1987 Mar;19(3):367-71. doi: 10.1093/jac/19.3.367. J Antimicrob Chemother. 1987. PMID: 3471752

3

Cefotaxime: single agent therapy for infections in cancer patients with adequate granulocyte counts.

Rolston K, Bolivar R, Fainstein V, Jones P, Elting L, Bodey GP. Rolston K, et al. Among authors: fainstein v. J Antimicrob Chemother. 1985 Jan;15(1):91-6. doi: 10.1093/jac/15.1.91. J Antimicrob Chemother. 1985. PMID: 3972760

4

A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients.

Fainstein V, Bodey GP, Elting L, Bolivar R, Keating MJ, McCredie KB, Valdivieso M. Fainstein V, et al. J Antimicrob Chemother. 1983 Jul;12 Suppl A:101-10. doi: 10.1093/jac/12.suppl_a.101. J Antimicrob Chemother. 1983. PMID: 6352612 Clinical Trial.

5

Treatment of systemic fungal infections with liposomal amphotericin B.

Lopez-Berestein G, Bodey GP, Fainstein V, Keating M, Frankel LS, Zeluff B, Gentry L, Mehta K. Lopez-Berestein G, et al. Among authors: fainstein v. Arch Intern Med. 1989 Nov;149(11):2533-6. Arch Intern Med. 1989. PMID: 2818111

6

Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.

Anaissie EJ, Fainstein V, Bodey GP, Rolston K, Elting L, Kantarjian H, Cabanillas F, McCredie KB. Anaissie EJ, et al. Among authors: fainstein v. Am J Med. 1988 Mar;84(3 Pt 2):581-9. doi: 10.1016/0002-9343(88)90140-4. Am J Med. 1988. PMID: 3279774 Clinical Trial.

7

Imipenem/cilastatin therapy of infections in cancer patients.

Bodey GP, Elting L, Jones P, Alvarez ME, Rolston K, Fainstein V. Bodey GP, et al. Among authors: fainstein v. Cancer. 1987 Jul 15;60(2):255-62. doi: 10.1002/1097-0142(19870715)60:2<255::aid-cncr2820600224>3.0.co;2-l. Cancer. 1987. PMID: 3297282 Clinical Trial.

8

Imipenem/cilastatin as secondary therapy for infections in cancer patients.

Bodey GP, Rolston K, Jones P, Alvarez ME, Fainstein V, Steelhammer L. Bodey GP, et al. Among authors: fainstein v. J Antimicrob Chemother. 1986 Dec;18 Suppl E:161-6. doi: 10.1093/jac/18.supplement_e.161. J Antimicrob Chemother. 1986. PMID: 3469189

9

Aztreonam therapy in neutropenic patients with cancer.

Jones PG, Rolston KV, Fainstein V, Elting L, Walters RS, Bodey GP. Jones PG, et al. Among authors: fainstein v. Am J Med. 1986 Aug;81(2):243-8. doi: 10.1016/0002-9343(86)90258-5. Am J Med. 1986. PMID: 3526885 Clinical Trial.

10

Imipenem-cilastatin as initial therapy for febrile cancer patients.

Bodey GP, Alvarez ME, Jones PG, Rolston KV, Steelhammer L, Fainstein V. Bodey GP, et al. Among authors: fainstein v. Antimicrob Agents Chemother. 1986 Aug;30(2):211-4. doi: 10.1128/AAC.30.2.211. Antimicrob Agents Chemother. 1986. PMID: 3532942 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters